Zweig-DiMenna Associates LLC - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 53 filers reported holding SIGILON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Zweig-DiMenna Associates LLC ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,272,000
-44.9%
118,504
+14.8%
0.08%
-51.9%
Q1 2021$2,307,000
+674.2%
103,200
+1564.5%
0.16%
+742.1%
Q4 2020$298,0006,2000.02%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 10,370,369$58,592,0000.61%
HARBOURVEST PARTNERS LLC 740,740$4,185,0000.39%
Monashee Investment Management LLC 317,460$1,794,0000.33%
SOUNDMARK WEALTH MANAGEMENT, LLC 50,555$286,0000.10%
Artal Group S.A. 276,000$1,559,0000.04%
Choate Investment Advisors 66,666$377,0000.02%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$8,391,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 509,629$2,879,0000.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 229,500$1,297,0000.00%
Woodline Partners LP 34,200$193,0000.00%
View complete list of SIGILON THERAPEUTICS INC shareholders